about
Monogenic polyarteritis: the lesson of ADA2 deficiencyIn Vivo Chronic Stimulation Unveils Autoreactive Potential of Wiskott-Aldrich Syndrome Protein-Deficient B Cells.Homeostatic expansion of autoreactive immunoglobulin-secreting cells in the Rag2 mouse model of Omenn syndromeMurine Rankl-/- Mesenchymal Stromal Cells Display an Osteogenic Differentiation Defect Improved by a RANKL-Expressing Lentiviral Vector.Anti-CD3ε mAb improves thymic architecture and prevents autoimmune manifestations in a mouse model of Omenn syndrome: therapeutic implications.ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study.Cell-line specific chromatin acetylation at the Sox10-Pax3 enhancer site modulates the RET proto-oncogene expression.IL-10 critically modulates B cell responsiveness in Rankl-/- mice.Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseases.Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients.Cryopyrin associated periodic syndromes (CAPS): immunological characterization of knock-in mouse model to exploit novel approaches for the modulation of the NLRP3 inflammasome.Osteopetrosis rescue upon RANKL administration to Rankl(-/-) mice: a new therapy for human RANKL-dependent ARO.Genetic Predisposition to Familial Neuroblastoma: Identification of Two Novel Genomic Regions at 2p and 12pInterferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosusMesenchymal Stromal Cell-Seeded Biomimetic Scaffolds as a Factory of Soluble RANKL in Rankl-Deficient Osteopetrosis.Concomitant DDX1 and MYCN gain in neuroblastoma
P50
Q28067372-165EFEAC-749E-447A-B826-EA4B09E540E6Q30847399-FBDC59D2-DF09-4FFD-85FB-928CFD35DF7CQ33979830-5BB42ABF-311F-4D5C-95AE-642EF1A96F29Q39014215-57569FF5-4EEF-44CB-B93F-D3696F8ACEEEQ39598202-0E7C0F2E-8D74-47D7-AD26-F8995A359D13Q40056283-ED314FF9-DDCF-44E7-8429-2176C41DC291Q40717620-1CDB7204-47D3-40AD-889F-C4771690D5AEQ41137165-091935C1-D4C5-4B64-BF39-8EC1582536D7Q41195612-0C5565E3-CCBA-4E63-9A41-5DC2B8E9A27BQ53515532-CD4BD90F-F210-48D8-B7D0-D42240E6C561Q54989148-B2101A76-1E78-4311-BAD8-F00F28954620Q55056509-61FAAE53-0BC8-41A4-B1B0-E4D2011A8DF2Q58328226-A8F52AFF-AE80-45BE-9D68-E304495942AEQ61657757-161EE6E9-9616-4184-B149-3D75FAB9476CQ64960178-0D4BBED3-2756-475A-8649-82CEC5C6F047Q80567570-3D45B4A3-E69A-4632-B11A-5A7CF43F7CAC
P50
description
researcher ORCID ID = 0000-0002-5868-7699
@en
wetenschapper
@nl
name
Francesca Schena
@ast
Francesca Schena
@en
Francesca Schena
@es
Francesca Schena
@nl
type
label
Francesca Schena
@ast
Francesca Schena
@en
Francesca Schena
@es
Francesca Schena
@nl
prefLabel
Francesca Schena
@ast
Francesca Schena
@en
Francesca Schena
@es
Francesca Schena
@nl
P1153
7101961484
P31
P496
0000-0002-5868-7699